Quinazolinones as bromodomain inhibitors

1. A compound of Formula I:

or a stereoisomer, tautomer, or pharmaceutically acceptable salt thereof,

wherein:

W 1 is selected from N and CR 1 ;

W 2 is selected from N and CR 2 ;

W 3 is selected from N and CR 3 ;

W 4 is selected from N and CR 4 ;

X is selected from N and CH;

Y is selected from —S(O)—, —NH—, —NHCH 2 —, —NHCH 2 CH 2 —, and —NHCH 2 CH 2 CH 2 —,

wherein if Y is —NH—, —NHCH 2 —, —NHCH 2 CH 2 —, or —NHCH 2 CH 2 CH 2 —, then the nitrogen is attached to the B ring, and one or more hydrogens may be optionally substituted with alkyl(C 1 -C 3 ), halogen, hydroxyl, or amino;

R 1 , R 2 , R 3 , and R 4 are independently selected from hydrogen, alkyl, alkenyl, alkynyl, alkoxy, amino, aryloxy, aryl, hydroxyl, and halogen,

wherein each alkyl and alkoxy may be optionally substituted with hydroxyl, amino, or halogen,

wherein each aryl and aryloxy may be optionally substituted with halogen, alkoxy, or amino, and

wherein two adjacent substituents selected from R 1 , R 2 , R 3 , and R 4 may be connected in a 5- or 6-membered ring to form a bicyclic carbocycle or bicyclic heterocycle;

R 5 is selected from amino and 5- and 6-membered carbocycles and heterocycles;

R 6 is selected from hydrogen, alkoxy, alkyl, halogen, aminoalkyl, and thioalkyl; and

R 7 is selected from hydrogen, alkyl, alkoxy, thioalkyl, aminoalkyl, and halogen.

2. The compound of claim 1 , wherein the compound is a compound of Formula Ia:

or a stereoisomer, tautomer, or pharmaceutically acceptable salt thereof,

wherein:

X is selected from N and CH;

Y is selected from —S(O)—, —NH—, —NHCH 2 —, —NHCH 2 CH 2 —, and —NHCH 2 CH 2 CH 2 —,

wherein if Y is —NH—, —NHCH 2 —, —NHCH 2 CH 2 —, or —NHCH 2 CH 2 CH 2 —, then the nitrogen is attached to the B ring, and one or more hydrogens may be optionally substituted with alkyl(C 1 -C 3 ), halogen, hydroxyl, or amino;

R 1 and R 3 are independently selected from hydrogen, alkyl, alkenyl, alkynyl, alkoxy, amino, aryloxy, aryl, hydroxyl, and halogen,

wherein each alkyl and alkoxy may be optionally substituted with hydroxyl, amino, or halogen,

wherein each aryl and aryloxy may be optionally substituted with halogen, alkoxy, or amino;

R 5 is selected from amino and 5- and 6-membered carbocycles and heterocycles;

wherein the 5- and 6-membered carbocycles and heterocycles are selected from:

wherein the 5- and 6- membered carbocycles and heterocycles may be optionally substituted with halogen, amino, alkyl(C 1 -C 6 ), or alkoxy(C 1 -C 6 );

and wherein Ra is selected from hydrogen, methyl, ethyl, propyl, isopropyl, t-butyl, —C(O)Me, —C(O)Pr, —C(O)iPr, benzyl, —C(O)CF 3 , —C(O)-tBu, —C(O)NHiPr, —C(O)NMe 2 , —C(O)NHEt, —C(O)NH 2 , —C(O)CH(OH)CH 3 , —C(O)C(O)OMe, —CF 3 , —CH 2 CH 2 OH, —CH 2 CH 2 — amino, and —CH 2 CH 2 C(Me) 2 OH;

R 6 is selected from hydrogen, alkoxy, alkyl, halogen, aminoalkyl, and thioalkyl; and

R 7 is selected from hydrogen, alkyl, alkoxy, thioalkyl, aminoalkyl, and halogen.

3. The compound of claim 2 , wherein X is N.

4. The compound of claim 2 , wherein R 1 and R 3 are each independently an alkoxy group.

5. The compound of claim 4 , wherein R 1 and R 3 are each independently selected from methoxy, ethoxy, isopropoxy, and propoxy.

6. The compound of claim 5 , wherein R 1 and R 3 are each methoxy.

7. The compound of claim 2 , wherein R 1 is methoxy and R 3 is amino.

8. The compound of claim 2 , wherein Y is selected from —NH—, —NHCH 2 —, —NHCH 2 CH 2 —, and —NHCH 2 CH 2 CH 2 —, wherein the nitrogen attached to the B ring, and wherein one or more hydrogens may be optionally substituted with F, Me, or Cl.

9. The compound of claim 8 , wherein Y is —NH—.

10. The compound of claim 2 , wherein R 5 is selected from—NHRa and 5- and 6-membered carbocycles and heterocycles;

wherein the 5- and 6-membered carbocycles and heterocycles are selected from:

wherein the 5- and 6- membered carbocycles and heterocycles may be optionally substituted with halogen, amino, amide, alkyl(C 1 -C 6 ), or alkoxy(C 1 -C 6 );

and wherein Ra is selected from hydrogen, methyl, ethyl, propyl, isopropyl, t-butyl, —C(O)Me, —C(O)Pr, —C(O)iPr, benzyl, —C(O)CF 3 , —C(O)-tBu, —C(O)NHiPr, —C(O)NMe 2 , —C(O)NHEt, —C(O)NH 2 , —C(O)CH(OH)CH 3 , —C(O)C(O)OMe, —CF 3 , —CH 2 CH 2 OH, —CH 2 CH 2 -amino, and —CH 2 CH 2 C(Me) 2 OH.

11. The compound of claim 2 , wherein R 6 is selected from hydrogen, methyl, and methoxy.

12. The compound of claim 2 , wherein R 6 is selected from groups of Formula II:

wherein:

D is selected from O, N, and S;

E is selected from O and N;

R 9 is selected from hydrogen and alkyl,

wherein R 8 is present only if D is N;

R 9 and R 10 are independently selected from hydrogen, alkyl, and cycloalkyl,

wherein only one of R 9 and R 10 is present if E is O;

R 9 and R 10 may be connected to form a carbocycle or a heterocycle containing one or more heteroatoms; and

n is selected from 1, 2, and 3.

13. The compound of claim 11 , wherein R 6 is selected from:

14. The compound of claim 2 , wherein:

R 1 and R 3 are each alkoxy;

Y is selected from —NH—, —NHCH 2 —, —NHCH 2 CH 2 —, and —NHCH 2 CH 2 CH 2 —,

wherein the nitrogen is attached to the B ring;

R 5 is selected from —NHRa and 5- and 6-membered carbocycles and heterocycles, wherein the 5- and 6-membered carbocycles and heterocycles are selected from:

wherein Ra is selected from hydrogen, methyl, ethyl, propyl, isopropyl, t-butyl, —C(O)Me, —C(O)Pr, —C(O)iPr, benzyl, —C(O)CF 3 , —C(O)-tBu, —C(O)NHiPr, —C(O)NMe 2 , —C(O)NHEt, —C(O)NH 2 , —C(O)CH(OH)CH 3 , —C(O)C(O)OMe, —CF 3 , —CH 2 CH 2 OH, —CH 2 CH 2 amino, and —CH 2 CH 2 C(Me) 2 OH; and

R 6 is selected from hydrogen, methyl, and alkoxy, wherein the alkoxy is optionally substituted with hydroxyl or amino.

15. The compound of claim 2 , wherein:

R 1 is alkoxy;

R 3 is amino;

Y is selected from —NH—, —NHCH 2 —, —NHCH 2 CH 2 —, and —NHCH 2 CH 2 CH 2 —,

wherein the nitrogen is attached to the B ring;

R 5 is selected from—NHRa and 5- and 6-membered carbocycles and heterocycles, wherein the 5- and 6-membered carbocycles and heterocycles are selected from:

wherein Ra is selected from hydrogen, methyl, ethyl, propyl, isopropyl, t-butyl, —C(O)Me, —C(O)Pr, —C(O)iPr, benzyl, —C(O)CF 3 , —C(O)-tBu, —C(O)NHiPr, —C(O)NMe 2 , —C(O)NHEt, —C(O)NH 2 , —C(O)CH(OH)CH 3 , —C(O)C(O)OMe, —CF 3 , —CH 2 CH 2 OH, —CH 2 CH 2 amino, and —CH 2 CH 2 C(Me) 2 OH; and

R 6 is selected from hydrogen, methyl, and alkoxy, wherein the alkoxy is optionally substituted with hydroxyl or amino.

16. A compound selected from:

5,7-Dimethoxy-2-(4-methoxy-2-((1-methylpiperidin-4-yl)amino)phenyl)-quinazolin-4(3H)-one;

5,7-Dimethoxy-2-(4-methoxy-2-(4-methylpiperazine-1-carbonyl)phenyl) quinazolin-4(3H)-one;

2-(2-((1-isopropylpiperidin-4-yl)amino)-4-methoxyphenyl)-5,7-dimethoxyquinazolin-4(3H)-one;

5,7-Dimethoxy-2-(4-methoxy-2-((1-methylpyrrolidin-3-yl)amino)phenyl)quinazolin-4(3H)-one;

5,7-Dimethoxy-2-(4-methoxy-2-(methyl(1-methylpiperidin-4-yl)amino)phenyl) quinazolin-4(3H)-one;

5,7-Dimethoxy-2-(4-methoxy-2-(((1-methylpiperidin-4-yl)methyl)amino)phenyl) quinazolin-4(3H)-one;

5,7-Dimethoxy-2-(4-methoxy-2-(((1-methylpyrrolidin-3-yl)methyl)amino)phenyl)-quinazolin-4(3H)-one;

2-(2-((2-(Isopropylamino)ethyl)amino)-4-methoxyphenyl)-5, 7-dimethoxyquinazolin-4(3H)-one;

5,7-dimethoxy-2-(4-Methoxy-2-((tetrahydro-2H-pyran-4-yl)amino)-phenyl)quinazolin-4(3H)-one;

2-(2-((1-Isopropylpiperidin-4-yl)amino)phenyl)-5,7-dimethoxyquinazolin-4(3H)-one;

5,7-Dimethoxy-2-(4-methoxy-2-((2-(pyrrolidin-1-yl)ethyl)amino)phenyl)quinazolin-4(3H)-one;

5,7-Dimethoxy-2-(4-methoxy-2-((2-(piperidin-1-yl)ethyl)amino)-phenyl)quinazolin-4(3H)-one;

5,7-Dimethoxy-2-(4-methoxy-2-((3-morpholinopropyl)amino)-phenyl)quinazolin-4(3H)-one;

5,7-Dimethoxy-2-(4-methoxy-2-((2-morpholinoethyl)amino)phenyl)-quinazolin-4(3H)-one;

5,7-Dimethoxy-2-(4-methoxy-2-((3-(pyrrolidin-1-yl)propyl)amino)phenyl)quinazolin-4(3H)-one;

2-(2-(((1-Isopropylpyrrolidin-3-yl)methyl)amino)-4-methoxyphenyl)-5,7-dimethoxyquinazolin-4(3H)-one;

2-(2-(((1-Isopropylpyrrolidin-2-yl)methyl)amino)-4-methoxyphenyl)-5,7-dimethoxyquinazolin-4(3H)-one;

2-(3-((1-Isopropylpiperidin-4-yl)amino)pyridin-2-yl)-5,7-dimethoxyquinazolin-4(3H)-one;

2-(2((1-Isobutyrylpiperidin-4-yl)amino)-4-methoxyphenyl)-5,7-dimethoxyquinazolin-4(3H)-one;

2-(2-((3-(Isopropylamino)propyl)amino)-4-methoxyphenyl)-5,7-dimethoxyquinazolin-4(3H)-one;

5,7-Dimethoxy-2-(4-methoxy-2-(3-(methylpiperazin-1-yl)propyl)amino)-phenylquinazolin-4(3H)-one;

2-(2-((2-(4-Isopropylpiperazin-1-yl)ethyl)amino)-4-methoxyphenyl)-5,7-dimethoxyquinazolin-4(3H)-one;

5,7-Dimethoxy-2-[4-methoxy-2-(1-methylpiperidin-4-ylsulfinyl)phenyl]quinazolin-4(3H)-one;

5,7-Dimethoxy-2-(4-methoxy-2-((2-(piperazin-1-yl)ethyl)amino)phenyl)quinazolin-4(3H)-one;

5,7-Dimethoxy-2-(4-methoxy-2-((2-(4-methylpiperazin-1-yl)ethyl)amino)phenyl)-quinazolin-4(3H)-one;

2-(2-((1-Isopropylpiperidin-4-yl)amino)-5-methoxyphenyl)-5,7-dimethoxyquinazolin-4(3H)-one;

2-(3-((1-Isopropylpiperidin-4-yl)amino)phenyl)-5,7-dimethoxyquinazolin-4(3H)-one;

5,7-Dimethoxy-2-(4-methoxy-2-[3-(piperazin-1-yl)propylamino]phenyl)quinazolin-4(3H)-one;

2-(2-((4,4-Dimethylcyclohexyl)amino)-4-methoxyphenyl)-5,7-dimethoxyquinazolin-4(3H)-one;

2-(3-((1-Isopropylpiperidin-4-yl)amino)-5-methoxypyridin-2-yl)-5,7-dimethoxyquinazolin-4(3H)-one;

2-(2-((trans-4-(2-Hydroxypropan-2-yl)cyclohexyl)amino)-4-methoxyphenyl)-5,7-dimethoxyquinazolin-4(3H)-one;

2-(3-((1-Isobutyrylpiperidin-4-yl)amino)-5-methoxypyridin-2-yl)-5,7-dimethoxyquinazolin-4(3H)-one;

2-(4-Chloro-2-((1-isopropylpiperidin-4-yl)amino)phenyl)-5,7-dimethoxyquinazolin-4(3H)-one;

2-(4-Chloro-2-((1-isobutyrylpiperidin-4-yl)amino)phenyl)-5,7-dimethoxyquinazolin-4(3H)-one;

2-(2-((1-Benzylpiperidin-4-yl)amino)-4-methoxyphenyl)-5,7-dimethoxyquinazolin-4(3H)-one;

2-(−((1-Isobutyrylpiperidin-4-yl)amino)pyridin-2-yl)-5,7-dimethoxyquinazolin-4(3H)-one;

2-(3-((1-Acetylpiperidin-4-yl)amino)pyridine-2-yl)-5,7-dimethoxyquinazolin-4(3H)-one;

N-(cis-4-((2-(5,7-Dimethoxy-4-oxo-3,4-dihydroquinazolin-2-yl)-5-methoxypyridin-3-yl)amino)cyclohexyl)isobutyramide;

2-(2-((1-Acetylpiperidin-4-yl)amino)-4-methoxyphenyl)-5,7-dimethoxyquinazolin-4(3H)-one;

5,7-Dimethoxy-2-(5-methoxy-3-((1-methylpiperidin-4-yl)amino)pyridin-2-yl)quinazolin-4(3H)-one;

5,7-Dimethoxy-2-(3-(((1-methylpyrrolidin-3-yl)methyl)amino)pyridin-2-yl)quinazolin-4(3H)-one;

4-((2-(5,7-Dimethoxy-4-oxo-3,4-dihydroquinazolin-2-yl)pyridin-3-yl)amino)-N,N-dimethylpiperidine-1-carboxamide;

2-(3-((3-(Isopropylamino)propyl)amino)pyridin-2-yl)-5,7-dimethoxyquinazolin-4(3H)-one;

5,7-Dimethoxy-2-(3-((1-methylpiperidin-4-yl)amino)pyridine-2-yl)quinazolin-4(3H)-one;

cis-4-((2-(5,7-Dimethoxy-4-oxo-3,4-dihydroquinazolin-2-yl)-5-methoxypyridin-3-yl)amino)-N-isopropylcyclohexane-1-carboxamide;

5,7-Dimethoxy-2-(3-((1-(2,2,2-trifluoroacetyl)piperidin-4-yl)amino)pyridin-2-yl)quinazolin-4(3H)-one;

4-((2-(5,7-Dimethoxy-4-oxo-3,4-dihydroquinazolin-2-yl)pyridin-3-yl)amino)-N-isopropylpiperidine-1-carboxamide;

5,7-Dimethoxy-2-(3-((1-pivaloylpiperidin-4-yl)amino)pyridin-2-yl)quinazolin-4(3H)-one;

5,7-Dimethoxy-2-(3-((2-morpholinoethyl)amino)pyridine-2-yl)quinazolin-4(3H)-one;

2-(3-((1-Isopropylpiperidin-4-yl)amino)-5-(2-((1-isopropylpiperidin-4-yl)amino)ethoxy)pyridin-2-yl)-5,7-dimethoxyquinazolin-4(3H)-one;

2-(4-((2-(5,7-Dimethoxy-4-oxo-3,4-dihydroquinazolin-2-yl)pyridin-3-yl)amino)piperidin-1-yl)-N,N-dimethyl-2-oxoacetamide;

4-((2-(5,7-dimethoxy-4-oxo-3,4-dihydroquinazolin-2-yl)pyridin-3-yl)amino)-N-ethylpiperidine-1-carboxamide;

cis-4-((2-(5,7-Dimethoxy-4-oxo-3,4-dihydroquinazolin-2-yl)pyridin-3-yl)amino)-N,N-dimethylcyclohexane-1-carboxamide;

4-((2-(5, 7-Dimethoxy-4-oxo-3,4-dihydroquinazolin-2-yl)pyridin-3-yl)amino)piperidine-1-carboxamide;

Methyl-2-(4-((2-(5,7-dimethoxy-4-oxo-3,4-dihydroquinazolin-2-yl)pyridin-3-yl)amino)piperidin-1-yl)-2-oxoacetate;

N-(2-((2-(5, 7-Dimethoxy-4-oxo-3,4-dihydroquinazolin-2-yl)pyridin-3-yl)amino)ethyl)isobutyramide;

N-(3-((2-(5, 7-Dimethoxy-4-oxo-3,4-dihydroquinazolin-2-yl)pyridin-3-yl)amino)propyl)isobutyramide;

2-(3-((1-Isopropylpiperidin-4-yl)amino)pyridin-2-yl)-5-methoxypyrido[3,4-d]pyrimidin-4(3H)-one;

2-(3-((1-(2-Hydroxy-2-methylpropyl)piperidin-4-yl)amino)pyridin-2-yl)-5,7-dimethoxyquinazolin-4(3H)-one;

2-(3-((1-(2-hydroxypropanoyl)piperidin-4-yl)amino)pyridin-2-yl)-5,7-dimethoxyquinazolin-4(3H)-one;

2-(3-((1-Isopropylpiperidin-4-yl)amino)pyridin-2-yl)-5-methoxy-7-((4-methoxybenzyl)amino)quinazolin-4(3H)-one;

2-[5-(2-Hydroxyethoxy)-3-(1-isopropylpiperidin-4-ylamino)pyridin-2-yl]-5,7-dimethoxyquinazolin-4(3H)-one;

cis-4-((2-(5,7-Dimethoxy-4-oxo-3,4-dihydroquinazolin-2-yl)pyridin-3-yl)amino)-N-isopropylcyclohexane-1-carboxamide;

2-[5-(2-Hydroxyethoxy)-3-(1-isobutyroylpiperidin-4-ylamino)pyridin-2-yl]-5,7-dimethoxyquinazolin-4(3H)-one;

7-amino-2-(3-((1-Isopropylpiperidin-4-yl)amino)pyridin-2-yl)-5-methoxyquinazolin-4(3H)-one;

2-{3-(1-Isopropylpiperidin-4-ylamino)-5-[2-(pyrrolidin-1-yl)ethoxy]pyridin-2-yl}-5,7-dimethoxyquinazolin-4(3H)-one;

2-{5-[2-(Isopropylamino)ethoxy]-3-(1-isopropylpiperidin-4-ylamino)pyridin-2-yl}-5,7-dimethoxyquinazolin-4(3H)-one;

2-(3-((1-(1-Hydroxy-2-methylpropan-2-yl)piperidin-4-yl)amino)pyridin-2-yl)-5,7-dimethoxyquinazolin-4(3H)-one; and

7-(Ethylamino)-2-(3-((1-isopropylpiperidin-4-yl)amino)pyridin-2-yl)-5-methoxyquinazolin-4(3H)-one; and

stereoisomers, tautomers, and pharmaceutically acceptable salts thereof.

17. A pharmaceutical composition comprising the compound of claim 2 , or a stereoisomer, tautomer, or pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier.

18. A pharmaceutical composition comprising the compound of claim 1 , or a stereoisomer, tautomer, or pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier.

19. A pharmaceutical composition comprising the compound of claim 16 , or a stereoisomer, tautomer, or pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carder.